DJ AbbVie Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slid 1.33% to $185.58 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.58% to 5,663.94 and the Dow Jones Industrial Average rising 0.62% to 41,368.45.
AbbVie Inc. closed 15.13% below its 52-week high of $218.66, which the company reached on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.04% to $155.66, Pfizer Inc. $(PFE)$ rose 0.79% to $22.97, and Amgen Inc. $(AMGN)$ fell 1.37% to $272.05.
Data source: Dow Jones Market Data, FactSet. Data compiled May 8, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 08, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.